Literature DB >> 27882116

In vitro and in vivo assessment of high-dose vitamin C against murine tumors.

Guoping Wang1, Tao Yin1, Yongsheng Wang1.   

Abstract

Vitamin C is widely used in clinical settings and is well known for its safety. Previous studies have shown the efficacy of intravenous vitamin C; however, intratumoral delivery of vitamin C has yet to be attempted. In the present study, the biological effects of high-dose vitamin C on tumor cells were investigated in vitro by using the MTT assay and flow cytometry. When administered in vitro, high-dose vitamin C inhibited the proliferation of murine colon and breast cancer cells, and induced tumor cell apoptosis. Cytotoxicity of vitamin C was partially reversed by N-acetyl-cysteine at a relatively low dosage. In addition, synergistic anti-tumor effects of vitamin C and cisplatin were observed. In vivo, intratumoral delivery of vitamin C delayed tumor growth in murine solid tumor models. Considering its low toxicity and availability, the present study indicates that vitamin C may be a novel therapeutic method for patients with advanced tumors.

Entities:  

Keywords:  N-acetyl-cysteine; apoptosis; chemotherapy; proliferation; tumor; vitamin C

Year:  2016        PMID: 27882116      PMCID: PMC5103746          DOI: 10.3892/etm.2016.3707

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

Review 1.  Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

Authors:  Michael J González; Jorge R Miranda-Massari; Edna M Mora; Angelik Guzmán; Neil H Riordan; Hugh D Riordan; Joseph J Casciari; James A Jackson; Angel Román-Franco
Journal:  Integr Cancer Ther       Date:  2005-03       Impact factor: 3.279

2.  Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells.

Authors:  Atsushi Suzuki; Ángel Raya; Yasuhiko Kawakami; Masanobu Morita; Takaaki Matsui; Kinichi Nakashima; Fred H Gage; Concepción Rodríguez-Esteban; Juan Carlos Izpisúa Belmonte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

3.  High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.

Authors:  Yan Ma; Julia Chapman; Mark Levine; Kishore Polireddy; Jeanne Drisko; Qi Chen
Journal:  Sci Transl Med       Date:  2014-02-05       Impact factor: 17.956

4.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Authors:  M Levine; C Conry-Cantilena; Y Wang; R W Welch; P W Washko; K R Dhariwal; J B Park; A Lazarev; J F Graumlich; J King; L R Cantilena
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Intranasal administration of a combination of choline chloride, vitamin C, and selenium attenuates the allergic effect in a mouse model of airway disease.

Authors:  Preeti Bansal; Sanjay Saw; Dhanapal Govindaraj; Naveen Arora
Journal:  Free Radic Biol Med       Date:  2014-06-04       Impact factor: 7.376

6.  N-acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells.

Authors:  Athikom Supabphol; Verasing Muangman; Warinthorn Chavasiri; Roongtawan Supabphol; Wandee Gritsanapan
Journal:  J Med Assoc Thai       Date:  2009-09

7.  Vitamin C enhances Nanog expression via activation of the JAK/STAT signaling pathway.

Authors:  Haibo Wu; Yongyan Wu; Zhiying Ai; Liping Yang; Yuan Gao; Juan Du; Zekun Guo; Yong Zhang
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

8.  Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Authors:  E T Creagan; C G Moertel; J R O'Fallon; A J Schutt; M J O'Connell; J Rubin; S Frytak
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

9.  Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.

Authors:  L J Hoffer; M Levine; S Assouline; D Melnychuk; S J Padayatty; K Rosadiuk; C Rousseau; L Robitaille; W H Miller
Journal:  Ann Oncol       Date:  2008-06-09       Impact factor: 32.976

10.  Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.

Authors:  Qi Chen; Michael Graham Espey; Andrew Y Sun; Je-Hyuk Lee; Murali C Krishna; Emily Shacter; Peter L Choyke; Chaya Pooput; Kenneth L Kirk; Garry R Buettner; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

View more
  4 in total

Review 1.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

2.  Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer.

Authors:  Sherihan Salaheldin Abdelhamid Ibrahim; Sarah A Abd El-Aal; Ahmed M Reda; Samar El Achy; Yasmine Shahine
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

3.  A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice.

Authors:  Cheng-Wei Lai; Hsiao-Ling Chen; Min-Yu Tu; Wei-Yu Lin; Theresa Röhrig; Shang-Hsun Yang; Ying-Wei Lan; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Oncotarget       Date:  2017-01-31

Review 4.  High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.

Authors:  Franziska Böttger; Andrea Vallés-Martí; Loraine Cahn; Connie R Jimenez
Journal:  J Exp Clin Cancer Res       Date:  2021-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.